Site icon TRUTH IN PLAIN SIGHT

Pfizer Is Going To Make Approx. $30 Billion On Vaccines In 2021!

The COVID Vaccine Is Here … And So Are Potential Side Effects

Research who owns Pfizer shares? The results of the top organizations and their major individual shareholders are not surprising. Also explains why the censorship of anyone against the vaccine cash cow. Conflict of Interests is the new normal.

Top Shareholders of Pfizer

Who owns Pfizer?

Pfizer said Tuesday it plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech at the end of this month. If the FDA signs off, the company will be able to market the shot directly to consumers.

In its earnings report, Pfizer said first-quarter sales of its Covid-19 vaccine was $3.5 billion, roughly 24% of its revenue for the quarter. Its profit and revenue beat Wall Street’s expectations.

Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

The company now expects full-year sales of $26 billion from the vaccine, up from its previous forecast of about $15 billion. It expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.

Shares of Pfizer rose 1.3% in premarket trading.

“Based on what we’ve seen, we believe that a durable demand for our Covid-19 vaccine, similar to that of the flu vaccines, is a likely outcome,” Pfizer CEO Albert Bourla told investors on an earnings call.

Source: CNBC

Exit mobile version